wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

Infertility and Menstruation Disorders- Yero

Total questions: 40

Worksheet time: 30mins

Name
Class
Date
1.

JT is a 17-year-old female who complains of amenorrhea for 6 months. She experienced menarche at the age of 14 years. A pregnancy test is performed and found to be negative. She is a distance runner who describes her appetite as “healthy.” Her BMI is 21 kg/m2. What is the next step in evaluating this complaint?

a)

Check her serum prolactin concentration

b)

Check her thyroid-stimulating hormone (TSH) concentration

c)

Quantify her level of exercise

d)

Evaluate whether she may have anorexia

2.

KS is a 36-year-old female who has not had a period for 8 months. She is not pregnant; her serum prolactin concentration is observed to be twice the upper limit of normal. She displays no symptoms of polycystic ovary syndrome (PCOS). Which of the following is most appropriate for KS at this time?

a)

An oral contraceptive containing 30 µg ethinyl estradiol plus levonorgestrel

b)

Bromocriptine 2.5 mg by mouth three times daily

c)

Medroxyprogesterone acetate (MPA) 10 mg by mouth for 10 days

d)

Metformin 1,000 mg by mouth twice daily

3.

BJ is a 14-year-old girl who started having menses 7 months ago. Her menses is irregular, with cycle length ranging from 32 days to 75 days. What is the best course of action at this time?

a)

Evaluate BJ for hypothyroidism

b)

Evaluate BJ for polycystic ovary syndrome (PCOS)

c)

Evaluate BJ for bleeding disorders

d)

Educate BJ that her menstrual irregularity is expected

4.

Which of the following statements is true regarding the levonorgestrel-releasing intrauterine system in women with heavy menstrual bleeding?

a)

It should never be used in nulliparous women.

b)

It reduces menstrual flow by a maximum of 25%.

c)

It is a therapeutic option for any woman at low risk for sexually transmitted diseases.

d)

Its use increases the need for hysterectomy.

5.

Regardless of the etiology of amenorrhea, which of the following lifestyle interventions is most appropriate?

a)

Increase the dietary intake of folate and vitamin E

b)

Increase the dietary intake of calcium and vitamin D

c)

Decrease the intake of alcohol

d)

Decrease the level of exercise

6.

In women with PCOS whose primary concern is menstrual irregularity, and who are not attempting pregnancy, which of the following is the initial therapeutic option after a trial of applicable lifestyle intervention?

a)

Metformin

b)

A combination oral contraceptive containing ethinyl estradiol and drospirenone

c)

levonorgestrel-releasing intrauterine system

d)

Letrozole

7.

BB is a 32-year-old female who initially presented with complaints of irregular menses and excess hair growth around the jawline. She was diagnosed with PCOS and was started on an oral contraceptive and lifestyle modification. Today at her 6-month follow-up appointment, her BMI is 35 kg/m2, and her waist circumference is 40 inches (102 cm). A 2-hour oral glucose tolerance test suggests impaired glucose tolerance. Which of the following is the most appropriate option for BB at this time?

a)

Continue her oral contraceptive

b)

Discontinue her oral contraceptive and initiate a LNG-IUS

c)

Discontinue her oral contraceptive and initiate letrozole

d)

Add metformin

8.

Hyperkalemia is most likely to result from which of the following products used in the management of PCOS?

a)

A combination oral contraceptive containing ethinyl estradiol and drospirenone

b)

A combination oral contraceptive containing ethinyl estradiol and levonorgestrel

c)

Metformin 850 mg by mouth twice daily

d)

Injectable medroxyprogesterone acetate (MPA), 150 mg dosed every12 weeks

9.

JK has PCOS that was previously treated with a combined oral contraceptive. She has discontinued her oral contraceptive 14 months ago to attempt pregnancy. During these 14 months, she had two menstrual periods, both with heavy bleeding. Her pregnancy test today is negative. Which of the following is the most appropriate treatment?

a)

Clomiphene 50 mg daily orally for 5 days

b)

MPA 10 mg daily orally for 10 days

c)

MPA 10 mg daily orally for 10 days, followed by letrozole 2.5 mg orally daily for 5 days beginning on cycle day 3 after induced withdrawal bleeding

d)

MPA 10 mg daily orally for 10 days, followed by metformin 550 mg orally daily and titrated to 2,000 mg total daily dose

10.

Excessive anovulatory bleeding in the adolescent population should result in an evaluation for

a)

Hypoprothrombinemia

b)

Hyperandrogenism

c)

Hypoestrogenism

d)

Hypothyroidism

11.

Which of the following agents is most appropriate for the management of dysmenorrhea in an adolescent who is not sexually active?

a)

Depot MPA 150 mg intramuscularly every 12 weeks

b)

Ibuprofen 800 mg by mouth three times daily during menses

c)

LNG-IUS releasing 20-µg levonorgestrel daily

d)

Oral contraceptive with 35-µg ethinyl estradiol plus norgestimate daily

12.

The most cost-effective treatment for heavy menstrual bleeding is

a)

A combination oral contraceptive

b)

LNG-IUS

c)

Oral MPA

d)

Depot MPA

13.

Which of the following nonpharmacologic options is effective for the treatment of dysmenorrhea?

a)

High protein diet

b)

Topical ice packs

c)

Reduced exercise

d)

Topical heat

14.

Dysmenorrhea is experienced by as many as _______% of women of childbearing age.

a)

20

b)

40

c)

70

d)

90

15.

CO is a 30-year-old woman diagnosed with PMDD after charting her symptoms for two cycles and attempting nonpharmacologic interventions for her symptoms without much relief. She is married and does not wish to use any form of birth control. Which of the following agents would be most appropriate for managing CO’s PMDD?

a)

Continuous treatment with paroxetine

b)

Luteal phase treatment with fluoxetine

c)

Luteal phase treatment with sertraline

d)

90-µg levonorgestrel and 20-µg ethinyl estradiol dosed continuously for 12 months

16.

__________dysmenorrhea is not due to any pelvic disease.

a)

Primary

b)

Secondary

17.

What is the first line treatment for dysmenorrhea?

a)

NSAIDs

b)

Opiates

c)

SSRIs

d)

Oral Contraceptives

18.

__________ amenorrhea is the absence of periods for at least 3 previous cycles or 6 months in those that have previously menstruated.

a)

Primary

b)

Secondary

19.

Cyclic progestin can be used to induce monthly withdrawal bleeding and be used as contraception.

a)

True

b)

False

20.

The underlying cause of amenorrhea is not important when determining the best treatment option.

a)

True

b)

False

21.

What is the first line treatment for acute severe uterine bleeding ?

a)

surgery

b)

hormonal medication

c)

iron supplement

d)

NSAIDs

22.

Which is highly effective for menorrhagia but can cause hot flushes, vaginal dryness, insomnia and can lead to osteoporosis after 6 months?

a)

GnRH agonists

b)

Levonorgestrel-Releasing Intrauterine System

c)

Progestins

d)

Combined Oral Contraceptives

23.

How long should a patient use treatment with NSAIDs or oral contraceptive for dysmenorrhea before determining whether or not it is effective for them?

a)

4 months

b)

2 months

c)

3 menstrual cycles

d)

6 menstrual cycles

24.

Endometriosis is the most common gynecological disease and is commonly diagnosed between age _________

a)

30-50

b)

20-40

c)

50-70

d)

16-30

25.

Which of the following are symptoms of endometriosis?

a)

Pelvic pain

b)

Dysmenorrhea

c)

Dyspareunia

d)

Infertility

e)

Dyschezia

26.

What is the first approved treatment for endometriosis?

a)

Danazol

b)

GnRH

c)

Progestin-only therapy

d)

NSAIDs

27.

Infertility is defined by the failure to achieve clinical pregnancy after_______ of regular, unprotected sexual intercourse.

a)

12 months

b)

6 months if older than 35

c)

3 months

d)

2 years

28.

Which group of ovulation disorders is characterized by amenorrhea, low gonadotropins, and estrogen deficiency?

a)

I

b)

II

c)

III

29.

Which group of ovulation disorders is characterized by oligo-ovulation or anovulation; hyperandrogenism; polycystic ovaries on ultrasound scan and hyperprolactinemia amenorrhea?

a)

I

b)

II

c)

III

30.

Which group of ovulation disorders is characterized by amenorrhea and low estradiol?

a)

I

b)

II

c)

III

31.

What is the most common cause of infertility due to a tubal factor?

a)

PID

b)

STDs

c)

Mass compression

32.

Which of the following are nonpharmacological treatments for infertility?

a)

Smoking cessation

b)

Reduce or eliminate caffeine intake

c)

Discontinue marijuana use

d)

Clomiphene

33.

Clomiphene

a)

enhances normal follicular maturation process and ovulation

b)

stimulates the ovary directly

c)

stimulates release of gonadotropins

d)

Increases levels of FSH and LH

34.

Clomiphene treatment should be limited to

a)

6 ovulatory cycles

b)

3 ovulatory cycles

c)

1 year

d)

4 months

35.

Blurred vision, diplopia, hot flashes, headache, and nausea are adverse effects of

a)

Clomiphene

b)

Letrozole

c)

Anastrozole

d)

Gonadotropins

36.

Which is an injectable medication that act directly on the ovaries to induce follicular development?

a)

Gonadotropins

b)

Anastrozole

c)

Letrozole

d)

Clomiphene

37.

Which is an oral medication that is used off label to block aromatase and lower estrogen levels augmenting secretion of LH and FSH?

a)

Gonadotropins

b)

Anastrozole

c)

Letrozole

d)

Clomiphene

38.

Which of the following has an allergy alert for latex?

a)

GnRH antagonists

b)

Gonadotropins

c)

Clomiphene

d)

Letrozole

39.

Chorionic gonadotropin (u-hCG) is given _______, and Choriogonadotropin alfa (r-hCG) is given _______

a)

IM, SubQ

b)

IV, IM

c)

IM, IV

d)

SubQ, IM

40.

Which medication has a peanut allergy warning?

a)

Progesterone

b)

GnRH antagonist

c)

Gonadotropins

d)

Anastrozole